Open AccessBleeding and New Cancer Diagnosis in Patients With Atherosclerosis
Author(s) -
John W. Eikelboom,
Stuart J. Connolly,
Jackie Bosch,
Olga Shestakovska,
Victor Aboyans,
Marco Alings,
Sonia S. Anand,
Álvaro Avezum,
Scott D. Berkowitz,
Deepak L. Bhatt,
Nancy CookBruns,
Camilo Félix,
Keith A.A. Fox,
Robert G. Hart,
Aldo P. Maggioni,
Paul Moayyedi,
Martin O’Donnell,
Lars Rydén,
Peter Verhamme,
Petr Widimský,
Jun Zhu,
Salim Yusuf
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.119.041949
Subject(s) - medicine , hazard ratio , genitourinary system , cancer , gastrointestinal bleeding , gastrointestinal cancer , gastroenterology , urinary system , surgery , colorectal cancer , confidence interval
Patients treated with antithrombotic drugs are at risk of bleeding. Bleeding may be the first manifestation of underlying cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom